had a bit of a look back at vitrocard results, and seems like the results achieved were similar to what happened on the trial, just unfortunately they were achieved by standard of care too. since there was no control group in the vitrocard trial and it was open label, in hindsight it is quite amazing how carried away the Tis management were in manufacturing millions of dollars in product and wasting years in ema approvals without once looking to try to confirm or bolster the trial results.
the outcome from the trial coordinator seemed to be "one could hypothesise that the compound helps healing" and Tis management somehow turned this into outlandish claims which have unfortunately taken a proper trial to finally unravel.
still holding and recently bought a pocket full more despite my sizeable loss. I do believe that the ftt management has been shoulders above Tis of old, so will see what happens. definitely in the bottom drawer however...
FTT Price at posting:
0.2¢ Sentiment: None Disclosure: Held
